call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Formulation Development Outsourcing Market
Inquire Before Buying Request for Sample

Formulation Development Outsourcing Market

Home Healthcare And Pharmaceutical Formulation Development Outsourcing Market

Formulation Development Outsourcing Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Service (Pre-formulation, Formulation Development); By Formulation (Topical, Oral, Injectable); By Therapeutic Area (Oncology, Infectious Disease, Respiratory, Cardiovascular, Neurology, Hematology, Dermatology); By End User (Pharmaceutical Industries, Research & Academic Institutions); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: October 2023
  • Report ID: BWC23846
  • Available Format: PDF
  • Page: 400

Report Overview

A spurring demand for novel medications and an increasing focus on cost efficiency are projected to propel the expansion of the global formulation development outsourcing market during the forecast period between 2023 and 2029.

Global Formulation Development Outsourcing Market - Industry Trends & Forecast Report, 2029

Global formulation development outsourcing market size was estimated at USD 24.27 billion in 2022. During the forecast period between 2023 and 2029, the size of global formulation development outsourcing market is projected to grow at a CAGR of 7.03% reaching a value of USD 36.48 billion by 2029. Major growth drivers for the global formulation development outsourcing market include an increasing R&D cost, rising need for specialized expertise, and growing desire for cost savings. Due to time constraints and limited internal resources, outsourcing has become a prevalent strategy, offering advantages such as accelerated project timelines, increased access to specialized knowledge, and enhanced protection against subpar products. This trend is particularly prominent among drug developers across various levels, with a growing interest in outsourcing pharmaceutical formulation development and manufacturing, notably in emerging economies like India. The escalating demand for innovative medications, driven by the substantial burden of infectious and chronic diseases, is a primary catalyst for the formulation development sector's growth. Additionally, the industry's emphasis on improving the solubility of poorly water-soluble compounds for enhanced bioavailability, coupled with patent expirations, has contributed to the surge in outsourcing. The urgency to conduct clinical trials, accelerated by the COVID-19 pandemic, has led to substantial investments in R&D, further propelling the market. Rising R&D expenditures are expected to sustain the demand for formulation development outsourcing, especially among small and medium-sized pharmaceutical enterprises lacking in-house capabilities. This trend is also bolstered by the pharmaceutical sector's increasing collaboration with academic institutions, fostering the expansion of the formulation development outsourcing industry.

Formulation Development Outsourcing Market

Global Formulation Development Outsourcing Market – Overview

The global formulation development outsourcing market refers to the segment within the pharmaceutical and biotechnology industries where companies contract out the process of developing and optimizing the formulation of new drug products to specialized external service providers. This outsourcing typically involves tasks, such as pre-formulation studies, formulation design, analytical testing, and sometimes the production of clinical trial materials. The primary objective of outsourcing formulation development is to leverage the expertise, resources, and infrastructure of Contract Development and Manufacturing Organizations (CDMOs) or other specialized firms to streamline drug development processes, reduce costs, accelerate time-to-market, and ensure compliance with regulatory requirements. It is a strategic approach utilized by pharmaceutical companies to efficiently navigate the complex and highly regulated landscape of drug formulation, allowing them to focus on core research and development activities while benefiting from external expertise and capabilities.

Global Formulation Development Outsourcing Market

Growth Drivers

Increasing Demand for Innovative Medications

The formulation development outsourcing market is poised for growth, primarily driven by the growing need for the commercial production of pharmaceuticals and therapeutics, in tandem with the rising incidence of disorders worldwide. The American Cancer Society has projected a staggering 1,958,310 new cancer cases in the United States in 2023, underscoring the urgency for drug development. Also, the expiring pharmaceutical patents are catalyzing market expansion. Notably, the market benefits from the trend of prioritizing pharmaceutical patent protection. By outsourcing formulation development, pharmaceutical companies can mitigate financial risks, as it reduces the substantial capital investment typically required. This factor emerges as a significant catalyst for market growth.

Restraints

Data Security and Confidentiality Concerns

The growth of the global formulation development outsourcing market is hindered by data security and confidentiality concerns. Pharmaceutical companies often deal with sensitive and proprietary information during formulation development, making data protection a paramount issue. The risk of data breaches, intellectual property theft, and regulatory non-compliance can deter companies from outsourcing critical processes. Maintaining the confidentiality and security of data is crucial, and stringent measures are required to address these concerns effectively. Overcoming these challenges through robust data protection strategies and contractual agreements will be essential to fostering trust and facilitating the continued growth of the formulation development outsourcing market.

Global Formulation Development Outsourcing Market

Segmental Coverage

Global Formulation Development Outsourcing Market – By Service

Based on service, the global formulation development outsourcing market is bifurcated into Pre-formulation and Formulation Development segments. The formulation development segment is expected to hold a higher share in the global formulation development outsourcing market by service during the forecast period. Creating, optimizing, and testing pharmaceutical or chemical formulations demands specialized knowledge and experience. Many businesses opt to delegate this aspect of their operations to specialized firms with dedicated teams possessing the necessary training and expertise. By outsourcing formulation development, companies can mitigate the risk of regulatory non-compliance and developmental setbacks. Seasoned outsourcing partners offer valuable assistance in ensuring adherence to regulatory requirements due to their extensive experience in navigating such complexities. Also, formulation development outsourcing accelerates product development by leveraging streamlined processes and rapid access to innovative technology. Formulation development plays a pivotal role in all stages of clinical trials, and as the number of clinical studies surged from 293,251 in 2019 to 362,503 in 2021, this growth is poised to positively impact the formulation development outsourcing market.

Formulation Development Outsourcing Market Size

Global Formulation Development Outsourcing Market – By Formulation

Based on formulation, the global formulation development outsourcing market is divided into Topical, Oral, and Injectable segments. The oral segment holds the highest share in the global formulation development outsourcing market by formulation. The most commonly prescribed and consumed forms of medication include tablets and capsules, necessitating the formulation development process for these dosage forms. Regulatory approval procedures for oral medications are well-established and generally less complex compared to other dosage forms, making them easier to navigate. Pharmaceutical companies and contract research organizations (CROs) have accumulated significant expertise and knowledge in the field of oral dosage forms, reflecting a wealth of experience in this area.

Formulation Development Outsourcing Market Share

Global Formulation Development Outsourcing Market – By Therapeutic Area

Based on therapeutic area, the global formulation development outsourcing market is divided into Oncology, Infectious Disease, Respiratory, Cardiovascular, Neurology, Hematology, and Dermatology segments. The oncology segment dominates the global formulation development outsourcing market by therapeutic area. Oncology drugs are inherently complex, often requiring specialized formulations for effective delivery. The pursuit of novel therapies, increasing prevalence of cancer worldwide, and rapid advancements in oncology research have fueled the demand for formulation expertise. Pharmaceutical companies prefer outsourcing to specialized partners with proven capabilities in oncology formulation development, as it streamlines the development process, expedites regulatory approvals, and ensures optimal drug delivery. Consequently, the oncology sector's complexity and growth potential make it a dominant force in the formulation development outsourcing market.

Global Formulation Development Outsourcing Market – By End User

Based on end user, the global formulation development outsourcing market is split into Pharmaceutical Industries and Research & Academic Institutions segments. The pharmaceutical industries segment holds a higher share in the global market by end user. To streamline trial-related costs and timelines, many pharmaceutical companies opt to contract formulation services externally. The pharmaceutical sector readily embraces emerging scientific advancements, technology, and information. Formulation development outsourcing expedites the creation of enduring solutions, fosters collaborative efforts, and simplifies the exchange of research discoveries. Effectively transferring technologies and fostering sustainability can bolster the pharmaceutical industry's innovation capabilities. To ensure the success of safe and efficacious treatments, the industry should meticulously plan clinical trials, prioritizing patient well-being, ethical principles, and scientific credibility.

Formulation Development Outsourcing Market Analysis

Global Formulation Development Outsourcing Market – By Region

The in-depth research report on the global formulation development outsourcing market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America holds the highest share in the global formulation development outsourcing market, due to the increasing burden of chronic diseases and the concentration of key industry players. With many major drugs nearing patent expiration, these players are focusing on novel drug development. To expedite formulation development while saving time and resources on extensive clinical trials, pharmaceutical firms are turning to Contract Research Organizations (CROs) for outsourcing, boosting regional market growth. Also, collaborative research efforts, especially during the COVID-19 pandemic, involving institutions like BARDA and CEPI, are fast-tracking therapeutic and vaccine development. Strategic initiatives, exemplified by Recro Pharma's contract with a US government department, further contribute to market expansion. Consequently, the market is expected for substantial growth during the forecast period.

Competitive Landscape

Major players operating in the global formulation development outsourcing market include Aizant Drug Research Solutions Private Limited, Catalent Inc., Charles River Laboratories, Dr. Reddy’s Laboratories Ltd, Emergent BioSolutions Inc., Intertek Group plc, Irisys LLC (Recro Pharma), Laboratory Corporation of America Holdings, Lonza Group AG, Piramal Pharma Solutions, Quotient Sciences, Syngene International Limited (Biocon Limited), and Thermo Fisher Scientific Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In February 2022 - Berkshire Sterile Manufacturing (BSM), a contract manufacturer specializing in sterile filling, expanded its range of services by incorporating formulation development, lyophilization, and method development capabilities into its offerings, thus enhancing its ability to support its clients in drug production processes.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa 

Product/ Service Segmentation

Service, Formulation, Therapeutic Area, End User, Region

Key Players

Aizant Drug Research Solutions Private Limited, Catalent Inc., Charles River Laboratories, Dr. Reddy’s Laboratories Ltd, Emergent BioSolutions Inc., Intertek Group plc, Irisys LLC (Recro Pharma), Laboratory Corporation of America Holdings, Lonza Group AG, Piramal Pharma Solutions, Quotient Sciences, Syngene International Limited (Biocon Limited), Thermo Fisher Scientific Inc.

 

By Service

  • Pre-formulation

  • Formulation Development

By Formulation

  • Topical

  • Oral

  • Injectable

By Therapeutic Area

  • Oncology

  • Infectious Diseases

  • Respiratory

  • Cardiovascular

  • Neurology

  • Hematology

  • Dermatology

By End User

  • Pharmaceutical Industries

  • Research & Academic Institutions

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3.  Global Formulation Development Outsourcing Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Rising demand for novel medications
        2. Cost efficiency
      2. Restraints
        1. Data security and confidentiality concerns
        2. Quality control
      3. Opportunities
        1. Market expansion
        2. Diversification
      4. Challenges
        1. Regulatory compliance
        2. Competition
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4.  Global Formulation Development Outsourcing Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share and Forecast
      1. By Service
        1. Pre-formulation
        2. Formulation Development
      2. By Formulation
        1. Topical
        2. Oral
        3. Injectable
        4. Others
      3. By Therapeutic Area
        1. Oncology
        2. Infectious Disease
        3. Respiratory
        4. Cardiovascular
        5. Neurology
        6. Hematology
        7. Dermatology
        8. Others
      4. By End User
        1. Pharmaceutical Industries
        2. Research & Academic Institutions
      5. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Formulation Development Outsourcing Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Service
      2. By Formulation
      3. By Therapeutic Area
      4. By End User
      5. By Country
        1. United States
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        2. Canada
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
  6. Europe Formulation Development Outsourcing Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Service
      2. By Formulation
      3. By Therapeutic Area
      4. By End User
      5. By Country
        1. Germany
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        2. United Kingdom
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        3. Italy
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        4. France
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        5. Spain
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        6. Belgium
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        7. Russia
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        8. The Netherlands
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        9. Rest of Europe
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
  7. Asia-Pacific Formulation Development Outsourcing Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Service
      2. By Formulation
      3. By Therapeutic Area
      4. By End User
      5. By Country
        1. China
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        2. India
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        3. Japan
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        4. South Korea
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        5. Australia & New Zealand
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        6. Indonesia
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        7. Malaysia
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        8. Singapore
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        9. Vietnam
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        10. Rest of APAC
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
  8. Latin America Formulation Development Outsourcing Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Service
      2. By Formulation
      3. By Therapeutic Area
      4. By End User
      5. By Country
        1. Brazil
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        2. Mexico
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        3. Argentina
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        4. Peru
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        5. Rest of LATAM
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
  9. Middle East & Africa Formulation Development Outsourcing Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Service
      2. By Formulation
      3. By Therapeutic Area
      4. By End User
      5. By Country
        1. Saudi Arabia
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        2. UAE
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        3. Qatar
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        4. Kuwait
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        5. South Africa
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        6. Nigeria
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        7. Algeria
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
        8. Rest of MEA
          1. By Service
          2. By Formulation
          3. By Therapeutic Area
          4. By End User
  10. Competitive Landscape
    1. List of Key Players and Their Services
    2. Global Formulation Development Outsourcing Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Formulation Development Outsourcing Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Aizant Drug Research Solutions Private Limited
    2. Catalent Inc.
    3. Charles River Laboratories
    4. Dr. Reddy’s Laboratories Ltd.
    5. Emergent BioSolutions Inc.
    6. Intertek Group plc
    7. Irisys LLC (Recro Pharma)
    8. Laboratory Corporation of America Holdings
    9. Lonza Group AG
    10. Piramal Pharma Solutions
    11. Quotient Sciences
    12. Syngene International Limited (Biocon Limited)
    13. Thermo Fisher Scientific Inc.
    14. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.    Qualitative Research
      1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Region
    5.    Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

 

Figure 1       Global Formulation Development Outsourcing Segmentation

Figure 2       Global Formulation Development Outsourcing Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 5       Global Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 6       Global Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 7       Global Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 8       Global Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 9       Global Formulation Development Outsourcing Market Share, By Region, By Value, 2019–2029

Figure 10     North America Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 11     North America Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 12     North America Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 13     North America Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 14     North America Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 15     North America Formulation Development Outsourcing Market Share, By Country, By Value, 2019–2029

Figure 16     United States Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 17     United States Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 18     United States Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 19     United States Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 20     United States Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 21     Canada Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 22     Canada Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 23     Canada Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 24     Canada Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 25     Canada Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 26     Europe Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 27     Europe Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 28     Europe Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 29     Europe Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 30     Europe Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 31     Europe Formulation Development Outsourcing Market Share, By Country, By Value, 2019–2029

Figure 32     Germany Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 33     Germany Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 34     Germany Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 35     Germany Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 36     Germany Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 37     United Kingdom Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 38     United Kingdom Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 39     United Kingdom Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 40     United Kingdom Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 41     United Kingdom Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 42     Italy Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 43     Italy Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 44     Italy Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 45     Italy Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 46     Italy Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 47     France Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 48     France Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 49     France Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 50     France Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 51     France Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 52     Spain Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 53     Spain Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 54     Spain Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 55     Spain Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 56     Spain Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 57     Belgium Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 58     Belgium Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 59     Belgium Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 60     Belgium Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 61     Belgium Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 62     Russia Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 63     Russia Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 64     Russia Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 65     Russia Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 66     Russia Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 67     The Netherlands Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 68     The Netherlands Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 69     The Netherlands Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 70     The Netherlands Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 71     The Netherlands Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 72     Rest of Europe Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 73     Rest of Europe Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 74     Rest of Europe Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 75     Rest of Europe Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 76     Rest of Europe Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 77     Asia-Pacific Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 78     Asia-Pacific Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 79     Asia-Pacific Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 80     Asia-Pacific Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 81     Asia-Pacific Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 82     Asia-Pacific Formulation Development Outsourcing Market Share, By Country, By Value, 2019–2029

Figure 83     China Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 84     China Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 85     China Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 86     China Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 87     China Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 88     India Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 89     India Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 90     India Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 91     India Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 92     India Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 93     Japan Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 94     Japan Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 95     Japan Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 96     Japan Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 97     Japan Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 98     South Korea Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 99     South Korea Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 100   South Korea Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 101   South Korea Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 102   South Korea Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 103   Australia & New Zealand Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 104   Australia & New Zealand Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 105   Australia & New Zealand Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 106   Australia & New Zealand Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 107   Australia & New Zealand Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 108   Indonesia Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 109   Indonesia Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 110   Indonesia Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 111   Indonesia Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 112   Indonesia Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 113   Malaysia Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 114   Malaysia Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 115   Malaysia Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 116   Malaysia Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 117   Malaysia Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 118   Singapore Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 119   Singapore Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 120   Singapore Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 121   Singapore Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 122   Singapore Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 123   Vietnam Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 124   Vietnam Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 125   Vietnam Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 126   Vietnam Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 127   Vietnam Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 128   Rest of APAC Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 129   Rest of APAC Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 130   Rest of APAC Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 131   Rest of APAC Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 132   Rest of APAC Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 133   Latin America Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 134   Latin America Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 135   Latin America Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 136   Latin America Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 137   Latin America Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 138   Latin America Formulation Development Outsourcing Market Share, By Country, By Value, 2019–2029

Figure 139   Brazil Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 140   Brazil Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 141   Brazil Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 142   Brazil Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 143   Brazil Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 144   Mexico Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 145   Mexico Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 146   Mexico Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 147   Mexico Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 148   Mexico Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 149   Argentina Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 150   Argentina Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 151   Argentina Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 152   Argentina Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 153   Argentina Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 154   Peru Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 155   Peru Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 156   Peru Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 157   Peru Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 158   Peru Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 159   Rest of LATAM Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 160   Rest of LATAM Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 161   Rest of LATAM Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 162   Rest of LATAM Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 163   Rest of LATAM Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 164   Middle East & Africa Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 165   Middle East & Africa Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 166   Middle East & Africa Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 167   Middle East & Africa Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 168   Middle East & Africa Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 169   Middle East & Africa Formulation Development Outsourcing Market Share, By Country, By Value, 2019–2029

Figure 170   Saudi Arabia Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 171   Saudi Arabia Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 172   Saudi Arabia Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 173   Saudi Arabia Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 174   Saudi Arabia Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 175   UAE Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 176   UAE Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 177   UAE Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 178   UAE Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 179   UAE Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 180   Qatar Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 181   Qatar Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 182   Qatar Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 183   Qatar Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 184   Qatar Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 185   Kuwait Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 186   Kuwait Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 187   Kuwait Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 188   Kuwait Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 189   Kuwait Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 190   South Africa Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 191   South Africa Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 192   South Africa Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 193   South Africa Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 194   South Africa Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 195   Nigeria Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 196   Nigeria Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 197   Nigeria Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 198   Nigeria Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 199   Nigeria Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 200   Algeria Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 201   Algeria Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 202   Algeria Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 203   Algeria Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 204   Algeria Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Figure 205   Rest of MEA Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Figure 206   Rest of MEA Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Figure 207   Rest of MEA Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Figure 208   Rest of MEA Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 209   Rest of MEA Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

 

 

List of Tables

 

Table 1 Global Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 2 Global Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 3 Global Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 4 Global Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 5 Global Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 6 Global Formulation Development Outsourcing Market Share, By Region, By Value, 2019–2029

Table 7 North America Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 8 North America Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 9 North America Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 10      North America Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 11      North America Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 12      North America Formulation Development Outsourcing Market Share, By Country, By Value, 2019–2029

Table 13      United States Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 14      United States Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 15      United States Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 16      United States Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 17      United States Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 18      Canada Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 19      Canada Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 20      Canada Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 21      Canada Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 22      Canada Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 23      Europe Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 24      Europe Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 25      Europe Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 26      Europe Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 27      Europe Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 28      Europe Formulation Development Outsourcing Market Share, By Country, By Value, 2019–2029

Table 29      Germany Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 30      Germany Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 31      Germany Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 32      Germany Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 33      Germany Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 34      United Kingdom Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 35      United Kingdom Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 36      United Kingdom Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 37      United Kingdom Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 38      United Kingdom Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 39      Italy Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 40      Italy Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 41      Italy Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 42      Italy Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 43      Italy Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 44      France Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 45      France Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 46      France Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 47      France Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 48      France Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 49      Spain Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 50      Spain Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 51      Spain Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 52      Spain Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 53      Spain Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 54      Belgium Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 55      Belgium Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 56      Belgium Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 57      Belgium Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 58      Belgium Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 59      Russia Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 60      Russia Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 61      Russia Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 62      Russia Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 63      Russia Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 64      The Netherlands Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 65      The Netherlands Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 66      The Netherlands Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 67      The Netherlands Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 68      The Netherlands Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 69      Rest of Europe Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 70      Rest of Europe Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 71      Rest of Europe Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 72      Rest of Europe Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 73      Rest of Europe Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 74      Asia-Pacific Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 75      Asia-Pacific Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 76      Asia-Pacific Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 77      Asia-Pacific Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 78      Asia-Pacific Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 79      Asia-Pacific Formulation Development Outsourcing Market Share, By Country, By Value, 2019–2029

Table 80      China Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 81      China Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 82      China Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 83      China Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 84      China Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 85      India Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 86      India Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 87      India Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 88      India Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 89      India Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 90      Japan Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 91      Japan Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 92      Japan Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 93      Japan Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 94      Japan Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 95      South Korea Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 96      South Korea Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 97      South Korea Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 98      South Korea Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 99      South Korea Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 100    Australia & New Zealand Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 101    Australia & New Zealand Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 102    Australia & New Zealand Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 103    Australia & New Zealand Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 104    Australia & New Zealand Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 105    Indonesia Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 106    Indonesia Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 107    Indonesia Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 108    Indonesia Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 109    Indonesia Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 110    Malaysia Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 111    Malaysia Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 112    Malaysia Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 113    Malaysia Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 114    Malaysia Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 115    Singapore Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 116    Singapore Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 117    Singapore Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 118    Singapore Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 119    Singapore Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 120    Vietnam Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 121    Vietnam Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 122    Vietnam Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 123    Vietnam Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 124    Vietnam Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 125    Rest of APAC Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 126    Rest of APAC Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 127    Rest of APAC Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 128    Rest of APAC Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 129    Rest of APAC Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 130    Latin America Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 131    Latin America Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 132    Latin America Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 133    Latin America Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 134    Latin America Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 135    Latin America Formulation Development Outsourcing Market Share, By Country, By Value, 2019–2029

Table 136    Brazil Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 137    Brazil Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 138    Brazil Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 139    Brazil Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 140    Brazil Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 141    Mexico Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 142    Mexico Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 143    Mexico Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 144    Mexico Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 145    Mexico Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 146    Argentina Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 147    Argentina Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 148    Argentina Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 149    Argentina Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 150    Argentina Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 151    Peru Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 152    Peru Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 153    Peru Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 154    Peru Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 155    Peru Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 156    Rest of LATAM Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 157    Rest of LATAM Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 158    Rest of LATAM Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 159    Rest of LATAM Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 160    Rest of LATAM Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 161    Middle East & Africa Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 162    Middle East & Africa Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 163    Middle East & Africa Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 164    Middle East & Africa Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 165    Middle East & Africa Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 166    Middle East & Africa Formulation Development Outsourcing Market Share, By Country, By Value, 2019–2029

Table 167    Saudi Arabia Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 168    Saudi Arabia Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 169    Saudi Arabia Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 170    Saudi Arabia Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 171    Saudi Arabia Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 172    UAE Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 173    UAE Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 174    UAE Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 175    UAE Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 176    UAE Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 177    Qatar Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 178    Qatar Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 179    Qatar Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 180    Qatar Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 181    Qatar Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 182    Kuwait Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 183    Kuwait Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 184    Kuwait Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 185    Kuwait Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 186    Kuwait Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 187    South Africa Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 188    South Africa Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 189    South Africa Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 190    South Africa Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 191    South Africa Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 192    Nigeria Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 193    Nigeria Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 194    Nigeria Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 195    Nigeria Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 196    Nigeria Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 197    Algeria Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 198    Algeria Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 199    Algeria Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 200    Algeria Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 201    Algeria Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 202    Rest of MEA Formulation Development Outsourcing Market Size, By Value (USD Billion), 2019–2029

Table 203    Rest of MEA Formulation Development Outsourcing Market Share, By Service, By Value, 2019–2029

Table 204    Rest of MEA Formulation Development Outsourcing Market Share, By Formulation, By Value, 2019–2029

Table 205    Rest of MEA Formulation Development Outsourcing Market Share, By Therapeutic Area, By Value, 2019–2029

Table 206    Rest of MEA Formulation Development Outsourcing Market Share, By End User Industry, By Value, 2019–2029

Table 207    Aizant Drug Research Solutions Private Limited Company Overview

Table 208    Aizant Drug Research Solutions Private Limited Financial Overview

Table 209    Catalent Inc. Company Overview

Table 210    Catalent Inc. Financial Overview

Table 211    Charles River Laboratories Company Overview

Table 212    Charles River Laboratories Financial Overview

Table 213    Dr. Reddy’s Laboratories Ltd. Company Overview

Table 214    Dr. Reddy’s Laboratories Ltd. Financial Overview

Table 215    Emergent BioSolutions Inc. Company Overview

Table 216    Emergent BioSolutions Inc. Financial Overview

Table 217    Intertek Group plc Company Overview

Table 218    Intertek Group plc Financial Overview

Table 219    Irisys LLC (Recro Pharma) Company Overview

Table 220    Irisys LLC (Recro Pharma) Financial Overview

Table 221    Laboratory Corporation of America Holdings Company Overview

Table 222    Laboratory Corporation of America Holdings Financial Overview

Table 223    Lonza Group AG Company Overview

Table 224    Lonza Group AG Financial Overview

Table 225    Piramal Pharma Solutions Company Overview

Table 226    Piramal Pharma Solutions Financial Overview

Table 227    Quotient Sciences Company Overview

Table 228    Quotient Sciences Financial Overview

Table 229    Syngene International Limited (Biocon Limited) Company Overview

Table 230    Syngene International Limited (Biocon Limited) Financial Overview

Table 231    Thermo Fisher Scientific Inc. Company Overview

Table 232    Thermo Fisher Scientific Inc. Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Global Formulation Development Outsourcing Market size was estimated at USD 24.27 billion in 2022.
Ans: Major factors driving the growth of the Global Formulation Development Outsourcing Market include the rising demand for novel medications and cost efficiency.
Ans: Key players in the Global Formulation Development Outsourcing Market include Aizant Drug Research Solutions Private Limited, Catalent Inc., Charles River Laboratories, Dr. Reddy’s Laboratories Ltd., Emergent BioSolutions Inc., Intertek Group plc, Irisys LLC (Recro Pharma), Laboratory Corporation of America Holdings, Lonza Group AG, Piramal Pharma Solutions, Quotient Sciences, Syngene International Limited (Biocon Limited), and Thermo Fisher Scientific Inc.
Ans: The formulation development segment is expected to hold a higher market share in the Global Formulation Development Outsourcing Market by service.
Ans: The oral segment holds the highest market share in the Global Formulation Development Outsourcing Market by formulation. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1732187972)
}